Excess glycine is thought to contribute to epilepsy phenotypes that arise in NKH, in particular owing to its action as a co‐agonist with glutamate at N‐methyl‐d‐aspartate (NMDA) receptors.13, 22. Here, AMT is linked to epilepsy.